PAKIANATHAN DEEPIKA 4
4 · Theravance Biopharma, Inc. · Filed May 21, 2025
Insider Transaction Report
Form 4
PAKIANATHAN DEEPIKA
Director
Transactions
- Award
Ordinary Shares
2025-05-19+10,649→ 58,065 total - Award
Share Option (Right to Buy)
2025-05-19+24,258→ 24,258 totalExercise: $9.39Exp: 2035-05-18→ Ordinary Shares (24,258 underlying)
Footnotes (1)
- [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.